Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jun Niijima"'
Autor:
Mitsuo Nagai, Daisuke Itoh, Yoshihiko Kotake, Naoki Asai, Regina Mikie Kanada, Shinya Abe, Yoshiharu Mizui, Jun Niijima
Publikováno v:
Angewandte Chemie International Edition. 46:4350-4355
Publikováno v:
The Journal of Antibiotics. 60:364-369
Pladienolide B is a 12-membered macrolide isolated from Streptomyces platensis Mer-11107. It showed potent in vitro and in vivo antitumor activities and is a potential lead for novel antitumor agents. The absolute configurations at ten chiral centers
Autor:
Kentaro Yoshimatsu, Katsuji Nakamura, Takeshi Nagasu, Hiroyuki Sugumi, Jun Niijima, Toshimi Okada, Toshimitsu Uenaka, Nozomu Koyanagi, Kappei Tsukahara, Atsumi Yamaguchi, Hiroshi Yoshino, Kyosuke Kitoh, Junichi Kamata, Yoshihiko Kotake
Publikováno v:
Chemical and Pharmaceutical Bulletin. 52:1071-1081
As part of a series of studies to discover new topoisomerase II inhibitors, novel pyrimidoacridones, pyrimidophenoxadines, and pyrimidocarbazoles were synthesized, and in vitro and in vivo antitumor activities and DNA-protein and/or DNA-topoisomerase
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 84
The present paper describes the selective determination of two synthetic intermediates (2,4-dichloro-6,7-dimethoxyquinazoline (IMP-1) and its derivative (IMP-2) as potential impurities in the active pharmaceutical ingredient (API)-A using two-dimensi
Autor:
Daisuke Itoh, Regina Mikie Kanada, Jun Niijima, Mitsuo Nagai, Yoshihiko Kotake, Shinya Abe, Yoshiharu Mizui, Naoki Asai
Publikováno v:
ChemInform. 38
Autor:
Toshimitsu Uenaka, Hiroshi Yoshino, Tomoyoshi Taniguchi, Takeshi Nagasu, Katsuji Nakamura, Yoshihiko Kotake, Nozomu Koyanagi, Hiroyuki Sugumi, Jun Niijima, Toshimi Okada, Kentaro Yoshimatsu, Atsumi Yamaguchi, Kyosuke Kitoh, Junichi Kamata
Publikováno v:
Cancer science. 94(1)
We have discovered a novel topoisomerase II (topo II) poison, ER-37328 (12,13-dihydro-5-[2-(dimethylamino)ethyl]-4H-benzo[c]pyrimido[5,6,1-jk]carbazole-4,6,10(5H,11H)-trione hydrochloride), which shows potent tumor regression activity against Colon 3
Autor:
Katsuji, Nakamura, Hiroyuki, Sugumi, Atsumi, Yamaguchi, Toshimitsu, Uenaka, Yoshihiko, Kotake, Toshimi, Okada, Junichi, Kamata, Jun, Niijima, Takeshi, Nagasu, Nozomu, Koyanagi, Hiroshi, Yoshino, Kyosuke, Kitoh, Kentaro, Yoshimatsu
Publikováno v:
Molecular cancer therapeutics. 1(3)
DNA topoisomerase II has been shown to be an important therapeutic target in cancer chemotherapy. Here, we describe studies on the antitumor activity of a novel topoisomerase II inhibitor, ER-37328 [12,13-dihydro-5-[2-(dimethylamino)ethyl]-4H-benzo[c
Autor:
Hiroshi Yoshino, Norihiro Ueda, Jun Niijima, Hiroyuki Sugumi, Yoshihiko Kotake, Nozomu Koyanagi, Kentaro Yoshimatsu, Makoto Asada, Tatsuo Watanabe, Takeshi Nagasu, Kappei Tsukahara, Atsumi Iijima, Kyosuke Kitoh
Publikováno v:
Journal of medicinal chemistry. 35(13)
Autor:
Regina Mikie Kanada, Daisuke Itoh, Jun Niijima, Yoshiharu Mizui, Shinya Abe, Mitsuo Nagai, Yoshihiko Kotake, Naoki Asai
Publikováno v:
Angewandte Chemie International Edition. 46:4194-4194
Autor:
Yoshihiko Kotake, Mitsuo Nagai, Naoki Asai, Shinya Abe, Daisuke Itoh, Jun Niijima, Regina Mikie Kanada, Yoshiharu Mizui
Publikováno v:
Angewandte Chemie. 119:4272-4272